with ruxolitinib compared to placebo plus ruxolitinib in JAKi-naïve myelofibrosis patients with platelet counts >100 x 109/L (N=353). Patients were randomized 2-to-1 to the selinexor arm. The co-primary endpoints for this trial are spleen volume...
Its trajectory can often be changed: AASLD guidance indicates 3 to 5% weight loss can improve steatosis, with above 10% needed to improve steatohepatitis and fibrosis What does the Choose Health Comprehensive Liver Function Test measure? The test...
Abbott the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) authorization of its Libre Duo 10 Day system, the world's first dual glucose‑ketone sensing technology. The new biowearable is designed to alert people...
for people with HER2+ advanced GEA. Ziihera is now the first and only bispecific HER2-targeted antibody combined with a PD-1 inhibitor and chemotherapy approved for all HER2+ advanced GEA patients, regardless of PD-L1 status, establishing a new...
About Rett Syndrome Rett syndrome is a rare, complex, neurodevelopmental disorder and occurs in approximately one of every 10,000 to 15,000 female births worldwide.1-3 A child with Rett syndrome generally exhibits an early period of apparently...
Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), announced the recent launch of Glatiramer Acetate Injection in 20 mg/mL and 40 mg/mL strengths, adding to the Company's portfolio of complex...
precision for individualised prescribing. CBPMs manufactured with WaterClear THC™ are supplied in 5 mg and 10 mg capsules, a 25 mg/mL oral dose spray, and a 25 mg/mL oily dropper solution. These may be prescribed where clinically appropriate under...
Tim Czartoski, orthopedic executive and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device...
NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The approval...
About Atinary Technologies Atinary Technologies is the pioneer of Self-Driving Labs®, a term its founders coined in 2017. Atinary's mission is to augment humans with AI and robotics to drive a Moore's Law of Discovery, exponentially accelerating...
often classified as having treatment-resistant depression, comprise approximately 30% of the overall MDD population1 and represent a significant unmet medical need. "Too many people I treat have carried depression for years, moving from one...
two decades of healthcare leadership experience and a strong track record of building high-performing businesses. During a 19-year career at Henry Schein, he spearheaded strategic, operational and commercial initiatives across key businesses. As...
the market leader in automated hand hygiene and infection prevention technology, announced that it has recorded more than 1 billion hand hygiene opportunities (HHOs) since the company’s founding in 2012. This milestone reflects the ongoing...
Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions...
during their second RSV season. Both the U.S. and EU applications are supported by data from the Phase 3 SMART trial (MK-1654-007), which were presented at RSVVW’26, the 9th conference of the Respiratory Syncytial Virus Foundation (ReSViNET), in...
(FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can...
Grows as Drug Spending Rises National prescription drug spending increased 7.9% to $467 billion in 2024 after growing 10.8% the previous year, according to the Centers for Medicare & Medicaid Services (CMS). Retail prescription drug spending is...
a clinical-grade supplement company specializing in evidence-based formulation, announced the launch of BioActive Vitamin B1™ Clinical Strength, a complete B1 activation system delivering 600mg benfotiamine at the research-matched dose alongside a...
more than digestion alone. resB specifically targets the Gut-Lung Axis, using resbiotic's proprietary probiotic strains (RSB11®, RSB12®, and RSB13®) to support respiratory health from the inside out. Few places understand the need for daily...
to present eligible investors with the opportunity to participate in a $20 million financing for Thplasma comprising a $15 million equity investment and a $5 million venture debt facility. Thplasma is a U.S.-based pharmaceutical company operating...